Table 3

Prognostic value of FPG, 2h-PG, and HbA1c for the primary composite end point in 3,775 coronary heart disease patients free of diabetes at baseline

NComposite end point,P*
HR (95% CI)
FPG (mmol/L)
 <6.11,5021
 6.1–6.91,4611.07 (0.80–1.42)0.66
 ≥78121.18 (0.85–1.64) 0.33
2h-PG (mmol/L)
 <7.82,0981
 7.8–11.01,2421.36 (1.04–1.80) 0.03
 ≥11.14351.44 (0.99–2.10) 0.06
HbA1c (%)
 <5.71,7971
 5.7–6.41,8041.14 (0.88–1.47)0.33
 ≥6.51741.00 (0.54–1.86)0.99
FPG (mmol/L)
 <6.11,5021
 ≥6.12,2731.10 (0.85–1.43) 0.45
2h-PG (mmol/L)
 <7.82,0981
 ≥7.81,6771.38 (1.07–1.78)0.01
HbA1c (%)
 <5.71,7971
 ≥5.71,9781.12 (0.87–1.45) 0.36
  • HR (95% CI) and P value adjusted for age and sex.

  • *P < 0.05 is statistically significant.